Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-25 Sale |
2025-02-27 5:00 pm |
Cullinan Therapeutics Inc. | CGEM | AHMED NADIM President and CEO |
12,529 | $8.53 | $106,872 | 430,621 (Direct) |
View |
| 2024-12-24 Sale |
2024-12-27 6:00 pm |
Cullinan Therapeutics Inc. | CGEM | AHMED NADIM President and CEO |
8,400 | $11.87 | $99,708 | 263,150 (Direct) |
View |
| 2023-12-26 Sale |
2023-12-27 6:30 pm |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
4,272 | $9.24 | $39,473 | 111,550 (Direct) |
View |
| 2023-06-28 Sale |
2023-06-29 4:59 pm |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
759 | $11.4 | $8,653 | 115,822 (Direct) |
View |
| 2023-05-23 Sale |
2023-05-24 4:36 pm |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
707 | $9.15 | $6,469 | 116,581 (Direct) |
View |
| 2023-04-25 Sale |
2023-04-26 4:23 pm |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
716 | $10.59 | $7,582 | 117,288 (Direct) |
View |
| 2023-03-23 Sale |
2023-03-27 4:05 pm |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
706 | $10.51 | $7,420 | 118,004 (Direct) |
View |
| 2022-06-06 Purchase |
2022-06-07 4:33 pm |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
8,090 | $12.4 | $100,316 | 8,090 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-19 Option Award |
2025-02-21 6:00 pm |
N/A 2035-02-19 |
Cullinan Therapeutics Inc. | CGEM | AHMED NADIM President and CEO |
540,000 | $0 | 803,150 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-23 5:00 pm |
N/A 2034-02-22 |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
480,000 | $0 | 591,550 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-23 5:06 pm |
N/A 2033-02-21 |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
320,000 | $0 | 329,710 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 6:04 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
1,620 | $10.9 | 9,710 (Direct) |
View |
| 2022-03-05 Option Award |
2022-03-07 9:50 pm |
N/A 2025-03-05 |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
215,000 | $0 | 215,000 (Direct) |
View |
| 2021-10-18 Option Award |
2021-10-20 4:35 pm |
N/A 2031-10-17 |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
2,710,000 | $0 | 2,710,000 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 8:13 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
7,660 | $62.03 | 40,855 (Direct) |
View |
| 2020-12-31 Exercise |
2021-01-05 8:13 pm |
N/A 2020-12-31 |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
14,946 | $0 | 40,855 (Direct) |
View |
| 2020-12-02 Tax Withholding |
2020-12-03 8:24 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
3,380 | $62.18 | 53,351 (Direct) |
View |
| 2020-12-02 Exercise |
2020-12-03 8:24 pm |
N/A 2023-12-02 |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
6,594 | $0 | 53,351 (Direct) |
View |
| 2020-10-30 Tax Withholding |
2020-11-03 4:28 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
2,291 | $58.45 | 30,355 (Direct) |
View |
| 2020-10-30 Exercise |
2020-11-03 4:28 pm |
N/A 2020-10-30 |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
4,650 | $0 | 30,355 (Direct) |
View |
| 2020-05-01 Tax Withholding |
2020-05-05 4:49 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
1,433 | $60.26 | 27,996 (Direct) |
View |
| 2020-05-01 Exercise |
2020-05-05 4:49 pm |
N/A 2020-05-01 |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
2,908 | $0 | 27,996 (Direct) |
View |